Related references
Note: Only part of the references are listed.Treatment with the Matricellular Protein CCN3 Blocks and/or Reverses Fibrosis Development in Obesity with Diabetic Nephropathy
Bruce L. Riser et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Fibrosis Caused by Loss of PTEN Expression in Mouse Fibroblasts Is Crucially Dependent on CCN2
Shangxi Liu et al.
ARTHRITIS AND RHEUMATISM (2013)
Hyperglycemia Causes Renal Cell Damage via CCN2-Induced Activation of the TrkA Receptor: Implications for Diabetic Nephropathy
Maria Fragiadaki et al.
DIABETES (2012)
CCN6 as a profibrotic mediator that stimulates the proliferation of lung fibroblasts via the integrin ß1/focal adhesion kinase pathway
Rentsenkhand Batmunkh et al.
JOURNAL OF MEDICAL INVESTIGATION (2011)
Connective Tissue Growth Factor-(CTGF, CCN2) - A Marker, Mediator and Therapeutic Target for Renal Fibrosis
Mysore K. Phanish et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2010)
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease
Bruce L. Riser et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2010)
CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease
Bruce L. Riser et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Noncanonical transforming growth factor β signaling in scleroderma fibrosis
Maria Trojanowska
CURRENT OPINION IN RHEUMATOLOGY (2009)
Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2
Andrew Leask
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Connective tissue growth factor and renal diseases: some answers, more questions
NA Wahab et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2004)
Proposal for a unified CCN nomenclature
DR Brigstock et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2003)
Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy
IE Blom et al.
MATRIX BIOLOGY (2002)
Share Paper
